![Sujal Shah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sujal Shah
No open positions remaining
Net worth: - $ as of 2026-08-30
Profile
Sujal Shah currently works at Tvardi Therapeutics, Inc., as Chairman from 2025.
Mr. Shah also formerly worked at CymaBay Therapeutics, Inc., as President, Chief Executive Officer & Director from 2017 to 2024, Tvardi Therapeutics, Inc. (Old), as Chairman from 2024 to 2025, Citigroup, Inc., as Director-Health Care Investment Banking from 2010 to 2012, Opthea Ltd., as Independent Non-Executive Director from 2024 to 2025, and Credit Suisse Global Opportunities Advisors LLC, as Vice President-Healthcare Investment Banking Group from 2004 to 2010.
Mr. Shah received his undergraduate degree and graduate degree from Northwestern University and Masters Business Admin degree from Tepper School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-09-04 | 0 ( -.--% ) | - $ | 2026-08-30 | |
-.--% | 2026-06-08 | 0 ( -.--% ) | - $ | 2026-08-30 |
Sujal Shah active positions
| Companies | Position | Start |
|---|
Former positions of Sujal Shah
| Companies | Position | End |
|---|---|---|
| CERYVYN THERAPEUTICS LIMITED | Director/Board Member | 2025-09-14 |
Tvardi Therapeutics, Inc.
 Tvardi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel and oral molecule therapies for STAT3 to treat fibrosis-driven diseases | Chairman | 2025-04-14 |
| CYMABAY THERAPEUTICS, INC. | Chief Executive Officer | 2024-03-21 |
| CITIGROUP INC. | Corporate Officer/Principal | 2011-12-31 |
Credit Suisse Global Opportunities Advisors LLC
 Credit Suisse Global Opportunities Advisors LLC Investment ManagersFinance Provides investment advice | Corporate Officer/Principal | 2009-12-31 |
Training of Sujal Shah
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
78
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Citigroup, Inc.
 Citigroup, Inc. Major BanksFinance Provides retail, investment, commercial banking, brand cards, securities sale & exchanges services | Finance |
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for people with life-threatening diseases | Health Technology |
Opthea Ltd.
 Opthea Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for treatment retinal diseases | Health Technology |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Credit Suisse Global Opportunities Advisors LLC
Credit Suisse Global Opportunities Advisors LLC Investment ManagersFinance Provides investment advice | Finance |
Tepper School of Business
 Tepper School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tvardi Therapeutics, Inc.
Tvardi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel and oral molecule therapies for STAT3 to treat fibrosis-driven diseases | Health Technology |
- Stock Market
- Insiders
- Sujal Shah
